Drug Shortage Report for CEFTAZIDIME FOR INJECTION BP

Last updated on 2019-05-14 History
Report ID 80088
Drug Identification Number 02437856
Brand name CEFTAZIDIME FOR INJECTION BP
Common or Proper name CEFTAZIDIME FOR INJECTION BP
Company Name STERIMAX INC
Market Status MARKETED
Active Ingredient(s) CEFTAZIDIME
Strength(s) 2G
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS
Packaging size 10 VIALS
ATC code J01DD
ATC description OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2019-03-29
Estimated end date 2019-04-26
Actual end date 2019-05-13
Shortage status Resolved
Updated date 2019-05-14
Company comments
Health Canada comments
Contact Address 2770 PORTLAND DRIVE
OAKVILLE, ONTARIO
CANADA L6H 6R4
Company contact information 1-800-881-3550

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2019-05-14 English Compare
v5 2019-05-13 French Compare
v4 2019-05-13 English Compare
v3 2019-03-30 English Compare
v2 2019-03-29 French Compare
v1 2019-03-29 English Compare